Nanobead-based interventions for the treatment and prevention of tuberculosis

Poor patient compliance and the spread of drug-resistant strains pose serious threats to anti-tuberculosis treatment regimens. In this Innovation article, Griffiths et al. review the potential advantages of using biodegradable nanoparticles as delivery systems for anti-tuberculosis drugs and vaccines.